国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

All parties benefit from negotiated cuts in pharmaceutical drug prices

China Daily | Updated: 2017-08-09 07:40
Share
Share - WeChat

Customers shop for over-the-counter medicines at a drugstore in Yinchuan, Ningxia Hui autonomous region, in this file photo. [Photo/Xinhua] 


THE MINISTRY OF HUMAN RESOURCES AND SOCIAL SECURITY published the result of the price negotiations on 36 medicines. The end-user price of the drugs has decreased by 44 percent on average, compared with their retail price last year, and they have been listed on the drug directory of the national medical insurance system. Beijing Youth Daily comments:

It is noteworthy that 15 out of the 36 medicines treat cancers and the rest are drugs for cardiovascular disease, hemophilia, and other serious illness.

The remarkable drop in the prices of these medicines resulted from the negotiations between the government and the pharmaceutical companies, the first time such negotiations have taken place in China, and they will relieve the medical cost burden on patients.

There have long been calls for these expensive drugs to be covered by the national medical insurance fund. However, their previously high prices made it impossible for the fund to cover them.

Yet despite the decrease in the price of these medicines, the profits made by the pharmaceutical companies are unlikely to fall as the sales volume of the medicines now they are included in the medical insurance's drug directory will significantly increase.

The tangible benefits the negotiations have produced are well worth the difficult and protracted discussions between the two parties. The purpose of the price negotiation is to look for an equilibrium point that can balance the interests of the medical insurance fund, patients and the drug enterprises, so as to make the whole system more sustainable.

The inclusion of the drugs in the medical insurance coverage directly improves the quality of the system and meets the needs of patients.

The price negotiation organized by the public health authorities enhances the transparency of the medicine pricing mechanism, and removes the middlemen, setting a good example as a conventional practice for the future.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
涞源县| 大城县| 枝江市| 岗巴县| 平乡县| 红桥区| 清水县| 雅安市| 高安市| 舒兰市| 孟连| 彝良县| 绥宁县| 双辽市| 湾仔区| 丹江口市| 万年县| 灌云县| 阜宁县| 比如县| 政和县| 静宁县| 铅山县| 秦安县| 富源县| 闸北区| 叙永县| 武乡县| 资源县| 大埔区| 沂源县| 马龙县| 军事| 青岛市| 呈贡县| 芮城县| 泗水县| 都江堰市| 陈巴尔虎旗| 林州市| 柳江县|